Publishing research using ab32088? Please let us know so that we can cite the reference in this datasheet.

ab32088 has been referenced in 7 publications.

  • Wang Q  et al. Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis. Oncogene N/A:N/A (2014). PubMed: 24632605
  • Cole CL  et al. Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling. J Biol Chem 289:10488-501 (2014). WB ; Human . PubMed: 24563483
  • Li L  et al. MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer. FEBS Lett 587:3921-7 (2013). WB . PubMed: 24211253
  • Li R  et al. Involvement of polo-like kinase 1 (Plk1) in mitotic arrest by inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase-ribosomal S6 kinase 1 (MEK-ERK-RSK1) cascade. J Biol Chem 287:15923-34 (2012). PubMed: 22427657
  • Trejo CL  et al. MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E. Cancer Res 72:3048-59 (2012). WB . PubMed: 22511580
  • Huynh H  et al. Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor. Mol Cancer Ther 8:152-9 (2009). PubMed: 19139124
  • Huynh H  et al. Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma. Mol Cancer Ther 6:138-46 (2007). PubMed: 17237274

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"